ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Aprea Therapeutics Inc

Aprea Therapeutics Inc (APRE)

4.00
0.04
( 1.01% )
Updated: 10:58:31

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000250k319k14k381k
Operating Income -98.47M-4.2M-2.65M-4.62M-3.65M-3.52M-3.68M-3.15M
Pre Tax Income -98.26M-4.03M-2.44M-4.38M-3.26M-3.2M-3.44M-2.81M
Net Income -98.26M-4.03M-2.44M-4.38M-3.26M-3.2M-3.44M-2.81M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -98.47M-4.2M-2.65M-4.62M-3.65M-3.52M-3.68M-3.15M
EBITDA -98.46M-4.2M-2.65M-4.62M-3.65M-3.52M-3.67M-3.14M
Year End December 30 2023 2017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000000583k
Operating Income -15.85M-16.49M-29.54M-52.81M-37.45M-113.39M-15.47M
Pre Tax Income -15.19M-15.53M-28.06M-53.48M-37.13M-112.66M-14.29M
Net Income -15.19M-15.53M-28.06M-53.48M-37.13M-112.66M-14.29M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) -2.707-1.816-0.973-1.843-1.251-10.746-1.271
EBIT -15.85M-16.49M-29.54M-52.81M-37.45M-113.39M-15.47M
EBITDA -15.84M-16.48M-29.37M-52.78M-37.43M-113.39M-15.47M

Your Recent History

Delayed Upgrade Clock